Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis

被引:0
|
作者
Östör, AJK
Chilvers, ER
Somerville, MF
Lim, AYN
Lane, SE
Crisp, AJ
Scott, DGI
机构
[1] Addenbrookes Hosp, Dept Rheumatol, Cambridge CB2 2QQ, England
[2] Norfolk & Norwich Univ Hosp, Dept Rheumatol, Norwich, Norfolk, England
[3] Univ Cambridge, Addenbrookes Hosp, Div Resp Med, Dept Med,Sch Clin Med, Cambridge CB2 2QQ, England
[4] Papworth Hosp, Cambridge CB3 8RE, England
关键词
rheumatoid arthritis; interstitial lung disease; infliximab; anti-tumor necrosis factor-alpha therapy; usual interstitial pneumonia; bronchiolitis obliterans organizing pneumonia;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe 5 patients with rheumatoid arthritis (RA) who developed pulmonary complications following infliximab therapy; 4 patients had preexisting usual interstitial pneumonia. As the pathophysiology of the pulmonary insult is unknown, we advise caution in the use of anti-tumor necrosis factor-alpha therapy in patients with RA with underlying lung disease of sufficient severity to withhold methotrexate treatment.
引用
收藏
页码:622 / 628
页数:7
相关论文
共 50 条
  • [41] Pleuro-Pulmonary Complications of Rheumatoid Arthritis
    Corcoran, John P.
    Ahmad, Mehreen
    Mukherjee, Rahul
    Redmond, Karen C.
    RESPIRATORY CARE, 2014, 59 (04) : E55 - E59
  • [42] Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient
    Josse, Severine
    Klemmer, Nathalie
    Moreno-Swirc, Sophie
    Goeb, Vincent
    Lequerre, Thierry
    Vittecoq, Olivier
    JOINT BONE SPINE, 2009, 76 (06) : 718 - 719
  • [43] New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients
    Tanno, Makoto
    Nakamura, Ichiro
    Kobayashi, Shunsuke
    Kurihara, Kumiko
    Ito, Katsumi
    CLINICAL RHEUMATOLOGY, 2006, 25 (06) : 929 - 933
  • [44] New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients
    Makoto Tanno
    Ichiro Nakamura
    Shunsuke Kobayashi
    Kumiko Kurihara
    Katsumi Ito
    Clinical Rheumatology, 2006, 25 : 929 - 933
  • [45] Immunologic criteria of effective infliximab therapy in RF-positive patients with rheumatoid arthritis
    Kalashnikova, T.
    Sizyakina, L.
    ALLERGY, 2011, 66 : 539 - 539
  • [46] Adalimumab in rheumatoid arthritis after failed infliximab and/or etanercept therapy: experience with 18 patients
    Brocq, O
    Albert, C
    Roux, C
    Gerard, D
    Breuil, V
    Ziegler, LE
    JOINT BONE SPINE, 2004, 71 (06) : 601 - 603
  • [47] The effect of infliximab therapy on the prevention of new erosions in patients with early rheumatoid arthritis.
    Smolen, J
    van der Heijde, D
    Devogelaer, JP
    Han, CL
    Bala, M
    Baker, D
    Han, J
    St Clair, EW
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S184 - S184
  • [48] Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis
    Allanore, Y
    Kahan, A
    Sellam, J
    Ekindjian, OG
    Borderie, D
    CLINICA CHIMICA ACTA, 2006, 365 (1-2) : 143 - 148
  • [49] Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus
    Zhang, Xuewu
    Zhang, Fengchun
    Wu, Donghai
    Bao, Chunde
    Zhu, Ping
    Zhang, Xiao
    Huang, Cibo
    He, DongYi
    Tao, Yi
    Fang, Yongfei
    Gu, Jieruo
    Wu, Huaxiang
    Sun, Lingyun
    Yang, Xiuyan
    Huang, Feng
    Xu, Huji
    Zhao, Dongbao
    Zhang, Miaojia
    Zheng, Yi
    Li, Zhanguo
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (04) : 408 - 412
  • [50] Infliximab therapy partially improves lipid profile in patients with refractory rheumatoid arthritis.
    Allanore, Y
    Borderie, D
    Ekindjian, O
    Kahan, A
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S393 - S393